KpATCC43816 Protein target profile

quinone oxidoreductase domain protein

Accession: VK055_1044

Gene: AIK79667.1 3D evidence: AlphaFold DB model + ColabFold model Metabolism 2 reactions UniProt A0A0H3GWM3
Length 327
Pocket druggability (P2Rank · AlphaFold DB model) 0.938
Metabolic reactions 2
Chokepoint No
Direct ligand evidence 0 53 total records
Functional annotation 1 EC 3 GO
Target summary

Target candidate with partial support; inspect missing evidence before prioritizing.

Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.

Terms and data sources used on this page

PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.

AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.

ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.

pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.

FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.

Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.

PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.

ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.

ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.

LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.

Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.

DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.

Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.

EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.

KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.

Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.

Prioritization evidence

Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.

Off-target risk

Human off-target
Hit
Human identity (%)
28.701 Lower values reduce human off-target concern.
Human E-value
4.32e-26
Gut microbiome similarity
0.2% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.

Essentiality

Essential (DEG)
N
DEG identity (%)
32.178 Higher values support similarity to known essential genes.

Structure confidence

ColabFold pLDDT
93.38 0-100 confidence; >70 supports local structural interpretation.

Binding-site evidence

AlphaFold DB / UniProt model

P2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.

Druggability (P2Rank) 0.938
Structure A0A0H3GWM3
Pocket Pocket 1
Druggability (FPocket) 0.223
Structure A0A0H3GWM3
Pocket Pocket 18
ColabFold model
P2Rank 0.924 · Pocket 1
FPocket 0.751 · Pocket 13
Core conservation Accessory gene
Roary core
CoreCruncher accessory
Gut microbiome 10 / 4744 genomes with a hit
Prevalence 0.2%

Metabolic context

Reactions catalyzed, pathway membership, and centrality in the genome-scale metabolic network.

Explore metabolic network
Relative network centrality 0.0% more central than 0.0% of genes in this genome
Chokepoint Not a chokepoint
Pathways

No specific KEGG pathway assigned - this reaction either has no KEGG mapping, or only matches a generic overview map with no route-level information.

Catalyzed reactions

2 reactions mapped to this gene in the metabolic model. Open the full network to see each one, with substrates/products and the reaction-reaction map.

Imported from KpATCC43816.sbml · 2026-07-09

Sequence

Primary amino-acid sequence viewer.

MIPTFVVWSQSMFNDAIVYDRYGPPAAVLTLKRLPLAPLAGGRVRVRMRFAPVNPSDLIPVTGAYRHRTRLPAVAGYEGLGEVVAAPYGSRLAAGQRVLPLRGGGTWQRFIDLDETWLVPVPPAVDDLLAARGYINPLTAMLMLKRWPVAGRHLVLTAASSSCASLLGQWALAMGARSVSGIIRSPQHRARLEQAGIYPILDTDRALMEKVSQHSDLVFDAVGGELANTLLSVLSASSTLISYGLLSGRPLTQTRGSATVRKFHLREALPTLSVAAWRAAFDEIWQRLPTTSQPPAQRIALNDWRAAIAAAGQPGRGGKILLDFTAG

Functional annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 3 GO

Subcellular localization

Localization
Unknown

Enzyme Commission (EC)

1

Gene Ontology (GO)

3
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
  • GO:0141148 Catalysis of the reaction: a 2,3-saturated acyl-[ACP] + NADP+ = a (2E)-enoyl-[ACP] + H+ + NADPH.
  • GO:0006633 The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.

Sequence domains and features

Domain and signature matches imported from InterPro and related databases.

10 records
Show feature table
Start End DB Term Name
15 257 PANTHER PTHR43981 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE, MITOCHONDRIAL
15 131 SUPERFAMILY SSF50129 GroES-like
15 131 InterPro IPR011032 GroES-like superfamily
134 292 Gene3D G3DSA:3.40.50.720 -
126 287 SUPERFAMILY SSF51735 NAD(P)-binding Rossmann-fold domains
126 287 InterPro IPR036291 NAD(P)-binding domain superfamily
26 322 SMART SM00829 PKS_ER_names_mod
26 322 InterPro IPR020843 Polyketide synthase, enoylreductase domain
17 323 CDD cd05282 ETR_like
16 309 Gene3D G3DSA:3.90.180.10 -

3D structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.

Download VMD script Full viewer

Loading 3D structure...

Drag to rotate — click the view, then scroll to zoom.

Pocket score High Medium Low
How colors and pocket overlays are used
Uniform protein color marks the displayed model as a single molecular object.
Experimental PDB structures may be colored by chain to distinguish subunits or copies present in the file.
Pocket colors and alpha spheres are evidence overlays for predicted binding cavities; they are not alternative protein chains.
'Alpha spheres' is FPocket's own cavity-shape geometry, imported when available and aligned with the loaded structure.
'Pocket atoms'/'Predicted site atoms' show the pocket's residue atoms instead: P2Rank reports residues rather than alpha spheres, and FPocket falls back to this when alpha-sphere geometry is unavailable or doesn't align.
'No pocket geometry' means neither alpha spheres nor residue-position data could be found for that pocket; the layer just highlights the same residues as 'Nearby residues'.
Pocket details Inspect a specific pocket, or open the full viewer

Binding pockets · P2Rank

Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2

Pocket 1 P2Rank #1
0.938
Likely same site as FPocket 18 6.1 Å 28 shared residues 68% of smaller site
Show in viewer
Surrounding area
Pocket 2 P2Rank #2
0.067
Show in viewer
Surrounding area
Pocket 3 P2Rank #3
0.009
Show in viewer
Surrounding area
Pocket 4 P2Rank #4
0.003
Show in viewer
Surrounding area

Binding pockets · FPocket

Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4

Pocket 1 FPocket #18
0.223 Unusual size
Likely same site as P2Rank 1 6.1 Å 28 shared residues 68% of smaller site
Show in viewer
Surrounding area
All structural evidence 0 experimental · 2 predicted

Structural evidence

0 + 2

Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold DB AF_A0A0H3GWM3
AlphaFold DB full sequence Viewing
ColabFold VK055_1044
ColabFold full sequence Loaded

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

53 records
Chemistry signal

Structural ligand evidence is available for this target.

Direct evidence 0 same-protein records
Transferred evidence 3 records from similar proteins
Structural ligands 3 0 loaded crystals
Measured bioactivity 0 direct and transferred ChEMBL records
Proposed compounds 50 similarity-based ZINC candidates
Best available ligand signal
COO PDB via homolog 835.6 Da · LogP -0.76 · TPSA 363.6 Open detail RCSB PDB
DIF PDB via homolog Detail RCSB PDB
X1H PDB via homolog Detail RCSB PDB
ZINC1281 ZINC proposed compound · Tanimoto 1.000 Detail ZINC
ZINC2506700 ZINC proposed compound · Tanimoto 0.800 Detail ZINC

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
COO RCSB PDB Q8WZM3 835.6 Da LogP -0.76 TPSA 363.6 3 viol. ✓ Clean CC=CC(=O)SCCNC(=O)CCNC(=O)[C@H](C(C)(C)CO[P@@](…
DIF RCSB PDB Q8N4Q0 296.2 Da LogP 4.36 TPSA 49.3 ✓ Ro5 ✓ Clean c1ccc(c(c1)CC(=O)O)Nc2c(cccc2Cl)Cl
X1H RCSB PDB Q8N4Q0 376.4 Da LogP 5.22 TPSA 66.8 1 viol. ✓ Clean COc1ccc(cc1)C(=O)c2c3ccc(cc3sc2c4ccc(cc4)O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.

Cross-references

External database identifiers for this protein, its structures, ligands, and metabolic reactions.